These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 2493037)
1. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone. Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037 [TBL] [Abstract][Full Text] [Related]
2. [Neurohormones coming from the normal and tumoral human anterior pituitary. Secretion and regulation in vitro]. Peillon F; Le Dafniet M; Garnier P; Feinstein MC; Donnadieu M; Barret A; Gautron JP; Brandi AM; Benlot C; Lagoguey A Pathol Biol (Paris); 1989 Sep; 37(7):840-5. PubMed ID: 2576565 [TBL] [Abstract][Full Text] [Related]
3. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin. Le Dafniet M; Lefebvre P; Barret A; Mechain C; Feinstein MC; Brandi AM; Peillon F J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264 [TBL] [Abstract][Full Text] [Related]
4. Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumors. Mouhieddine OE; Levy L; Benlot C; Peillon F; Joubert D J Clin Endocrinol Metab; 1995 May; 80(5):1691-5. PubMed ID: 7745020 [TBL] [Abstract][Full Text] [Related]
5. The interrelationship between the effects of insulin-like growth factor I and somatostatin on growth hormone secretion by normal rat pituitary cells: the role of glucocorticoids. Lamberts SW; den Holder F; Hofland LJ Endocrinology; 1989 Feb; 124(2):905-11. PubMed ID: 2492219 [TBL] [Abstract][Full Text] [Related]
6. [In vitro secretion of somatostatin (SRIH) by human adenomatous somatotropic cells. Relation with somatotropic hormone (GH) release and modulation by thyroliberin (TRH)]. Peillon F; Liappi G; Garnier P; Brandi AM; Evain-Brion D; Dodeur M; Gautron JP; Donnadieu M; Michard M; Racadot J C R Acad Sci III; 1988; 306(4):161-6. PubMed ID: 2896067 [TBL] [Abstract][Full Text] [Related]
7. Control of growth hormone secretion from porcine fetal and neonatal pituitary tissue in vitro by growth hormone-releasing hormone, somatostatin, and insulin-like growth factor. Torronteras R; Gracia-Navarro F; Elsaesser F Neuroendocrinology; 1997 Feb; 65(2):117-28. PubMed ID: 9067989 [TBL] [Abstract][Full Text] [Related]
8. [Neuropeptides of anterior pituitary origin]. Peillon F; Le Dafniet M; Pagesy P; Li JY; Benlot C; Lagoguey A; Brandi AM; Joubert D Ann Endocrinol (Paris); 1990; 51(3-4):133-6. PubMed ID: 2291627 [TBL] [Abstract][Full Text] [Related]
9. Neuropeptides of anterior pituitary origin. Autocrine or paracrine functions? Peillon F; Le Dafniet M; Pagesy P; Li JY; Benlot C; Brandi AM; Joubert D Pathol Res Pract; 1991 Jun; 187(5):577-80. PubMed ID: 1923952 [TBL] [Abstract][Full Text] [Related]
10. Leptin stimulates growth hormone secretion via a direct pituitary effect combined with a decreased somatostatin tone in a median eminence-pituitary perifusion study. Saleri R; Giustina A; Tamanini C; Valle D; Burattin A; Wehrenberg WB; Baratta M Neuroendocrinology; 2004; 79(4):221-8. PubMed ID: 15153755 [TBL] [Abstract][Full Text] [Related]
11. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture. Ishibashi M; Yamaji T J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494 [TBL] [Abstract][Full Text] [Related]
12. Presence and characterization of the somatostatin precursor in normal human pituitaries and in growth hormone secreting adenomas. Levy L; Bourdais J; Mouhieddine B; Benlot C; Villares S; Cohen P; Peillon F; Joubert D J Clin Endocrinol Metab; 1993 Jan; 76(1):85-90. PubMed ID: 8093621 [TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide. Renner U; Brockmeier S; Strasburger CJ; Lange M; Schopohl J; Müller OA; von Werder K; Stalla GK J Clin Endocrinol Metab; 1994 May; 78(5):1090-6. PubMed ID: 8175966 [TBL] [Abstract][Full Text] [Related]
14. Receptors and neurohormones in human pituitary adenomas. Peillon F; Le Dafniet M; Garnier P; Brandi AM; Moyse E; Birman P; Blumberg-Tick J; Grouselle D; Joubert-Bression D Horm Res; 1989; 31(1-2):13-8. PubMed ID: 2566572 [TBL] [Abstract][Full Text] [Related]
15. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion. Kelijman M; Frohman LA J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone-releasing hormone and somatostatin in normal and tumoral human pituitaries. Benlot C; Pagesy P; Peillon F; Joubert-Bression D Peptides; 1991; 12(5):945-50. PubMed ID: 1686935 [TBL] [Abstract][Full Text] [Related]
17. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly. Spada A; Elahi FR; Arosio M; Sartorio A; Guglielmino L; Vallar L; Faglia G J Clin Endocrinol Metab; 1987 Mar; 64(3):585-91. PubMed ID: 3102543 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone. Hofland LJ; van Koetsveld PM; van Vroonhoven CC; Stefanko SZ; Lamberts SW J Clin Endocrinol Metab; 1989 Mar; 68(3):613-20. PubMed ID: 2493040 [TBL] [Abstract][Full Text] [Related]
19. Autocrine and paracrine effects of peptides on human pituitary cells. Joubert D; Mouhieddine B; Benlot C; Levy L; Peillon F Horm Res; 1992; 38(1-2):100-4. PubMed ID: 1363983 [TBL] [Abstract][Full Text] [Related]
20. Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH. Evidence for somatotroph desensitization independent of GH pool depletion. Rittmaster RS; Loriaux DL; Merriam GR Neuroendocrinology; 1987 Feb; 45(2):118-22. PubMed ID: 2883595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]